BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10440695)

  • 1. Intratumoral heterogeneity of DNA content in renal cell carcinoma and its prognostic significance.
    Ruiz-Cerdá JL; Hernández M; Sempere A; O'Connor JE; Kimler BF; Jiménez-Cruz F
    Cancer; 1999 Aug; 86(4):664-71. PubMed ID: 10440695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
    Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
    Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
    Currin SM; Lee SE; Walther PJ
    J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
    del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
    Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometric DNA analysis on renal cell carcinoma--a study of 116 cases on fresh surgical specimens].
    Nakazawa H; Ito F; Okuda H; Ryoji O; Kihara T; Goya N; Takahashi K; Toma H
    Nihon Hinyokika Gakkai Zasshi; 1994 Feb; 85(2):242-50. PubMed ID: 8121106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study.
    Ljungberg B; Mehle C; Stenling R; Roos G
    Br J Cancer; 1996 Jul; 74(1):123-7. PubMed ID: 8679445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of flow cytometric, static cytometry and tumor cytogenetic investigation results human renal cell carcinomas].
    Krech RH; Baretton G; Fonatsch C; Diebold J; Früchtnicht W; Löhrs U
    Verh Dtsch Ges Pathol; 1990; 74():228-32. PubMed ID: 1708590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma.
    Di Silverio F; Casale P; Colella D; Andrea L; Seccareccia F; Sciarra A
    Cancer; 2000 Feb; 88(4):835-43. PubMed ID: 10679653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and clinical implication of cellular DNA content in renal cell carcinomas.
    Di Silverio F; Gallucci M; Flammia GP; De Vico A; Caponera M; Eleuteri P; Forte D; Cavallo D; De Vita R
    Eur Urol; 1992; 21 Suppl 1():43-7. PubMed ID: 1425835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of DNA ploidy in small renal cell carcinoma.
    Shalev M; Gdor Y; Leventis A; Radnay J; Shapiro H; Bernheim J; Nissenkorn I
    Pathol Res Pract; 2001; 197(1):7-12. PubMed ID: 11209819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy of oncocytic-granular renal cell carcinomas and renal oncocytomas by image analysis.
    Veloso JD; Solis OG; Barada JH; Fisher HA; Ross JS
    Arch Pathol Lab Med; 1992 Feb; 116(2):154-8. PubMed ID: 1733409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of deoxyribonucleic acid ploidy and nuclear morphometry for prediction of disease progression in renal cell carcinoma.
    Ruiz-Cerdá JL; Hernández M; Gomis F; Vera CD; Kimler BF; O'Connor JE; Jiménez-Cruz F
    J Urol; 1996 Feb; 155(2):459-65. PubMed ID: 8558635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity and progression of renal cell carcinomas as revealed by DNA cytofluorometry and the significance of the presence of polyploid cells.
    Kushima M; Kushima R; Hattori T; Tomoyoshi T
    Urol Res; 1995; 23(6):381-6. PubMed ID: 8788276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis?
    Skolarikos A; Alivizatos G; Bamias A; Mitropoulos D; Ferakis N; Deliveliotis C; Dimopoulos MA
    Int J Urol; 2005 Jun; 12(6):563-9. PubMed ID: 15985079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma.
    Ljungberg B; Larsson P; Stenling R; Roos G
    J Urol; 1991 Sep; 146(3):697-9. PubMed ID: 1875475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric analysis of DNA ploidy, cell cycle and cytomorphometry in sarcomatoid renal cell carcinoma.
    Yu DS; Wang J; Chang SY; Ma CP
    Eur Urol; 1991; 20(3):227-31. PubMed ID: 1823046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image analysis in the determination of ploidy and prognosis in renal cell carcinoma.
    Lanigan DJ; McLean PA; Murphy DM; Donovan MG; Leader M
    Eur Urol; 1992; 22(3):228-34. PubMed ID: 1468480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cell carcinoma. A clinicopathologic and DNA flow cytometric analysis of 103 cases.
    Grignon DJ; Ayala AG; el-Naggar A; Wishnow KI; Ro JY; Swanson DA; McLemore D; Giacco GG; Guinee VF
    Cancer; 1989 Nov; 64(10):2133-40. PubMed ID: 2804902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA content, nuclear grading and early tumor progression in renal cell cancer: a prospective study on frozen specimens.
    Cavazzana AO; Prayer-Galetti T; Sangiorgio A; Fassina AS; Panozzo M; Zucchetta P; Pagano F
    Eur Urol; 1992; 22(4):311-5. PubMed ID: 1490509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.